Jan 17, 2025

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics: 

• Introduction (0:00)
• Stages of Triple-Negative Breast Cancer (TNBC); Recurrence After Adjuvant Treatment (5:28)
• Long-Term Outcomes with Metastatic TNBC (11:55)
• Side Effects and Complications of Treatment (24:42)
• Dose...

Jan 16, 2025

Featuring perspectives from Dr Jeremy S Abramson, Dr Jennifer Crombie, Prof Martin Hutchings, Dr Matthew Lunning and Dr Tycel Phillips, moderated by Dr Abramson, including the following topics:

• Introduction (0:00)
• Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr...

Jan 14, 2025

Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein, including the following topics:

• Introduction (0:00)
• Current Clinical Decision-Making for Myelofibrosis (MF) in the Absence of Severe Cytopenias — Dr Kuykendall (2:53)

Jan 10, 2025

Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy and Dr Sara M Tolaney, including the following topics:

• Introduction (0:00)
• Optimizing the Care of Patients with HER2-Positive Metastatic Breast Cancer (mBC) — Dr Krop (10:17)
• Selection and Sequencing of Therapy...

Jan 9, 2025

Featuring perspectives from Prof Andreas Hochhaus, Dr Michael J Mauro and Dr B Douglas Smith, moderated by Dr Mauro, including the following topics:

• Introduction (0:00)
• Up-Front Therapy for Chronic Myeloid Leukemia (CML) — Prof Hochhaus (2:45)
• Management of Relapsed CML, Including in Patients with a T315I Mutation...